0001209191-22-014663.txt : 20220302 0001209191-22-014663.hdr.sgml : 20220302 20220302160218 ACCESSION NUMBER: 0001209191-22-014663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KNIGHT SUSAN E CENTRAL INDEX KEY: 0001183157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23837 FILM NUMBER: 22703319 MAIL ADDRESS: STREET 1: 9154 BRECKENRIDGE LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SURMODICS INC CENTRAL INDEX KEY: 0000924717 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411356149 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 9924 W 74TH ST CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: 9525007000 MAIL ADDRESS: STREET 1: 9924 WEST 74TH ST CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: BSI CORP DATE OF NAME CHANGE: 19970506 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-28 0 0000924717 SURMODICS INC SRDX 0001183157 KNIGHT SUSAN E 9154 BRECKENRIDGE LANE EDEN PRAIRIE MN 55437 1 0 0 0 Common Stock 2022-02-28 4 M 0 4366 20.18 A 34562 D Common Stock 2022-02-28 4 S 0 4366 44.9683 D 30196 D Stock Option (right to buy) 20.18 2022-02-28 4 M 0 4366 0.00 D 2022-12-18 Common Stock 4366 0 D Reflects the weighted average price of 4,366 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 28, 2022 with sale prices ranging from $44.96 to $45.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The amount beneficially owned includes 13,203 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. Fully vested. /s/ John Manders, on behalf of Susan E. Knight 2022-03-02